{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:00:12Z","timestamp":1780401612415,"version":"3.54.1"},"reference-count":118,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T00:00:00Z","timestamp":1426636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0116092","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T20:23:20Z","timestamp":1426710200000},"page":"e0116092","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Upregulation of Glycolytic Enzymes, Mitochondrial Dysfunction and Increased Cytotoxicity in Glial Cells Treated with Alzheimer\u2019s Disease Plasma"],"prefix":"10.1371","volume":"10","author":[{"given":"Tharusha","family":"Jayasena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nady","family":"Braidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Smythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Brodaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Trollor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kochan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perminder","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pneurobio.2003.08.001","article-title":"Yin and Yang: complement activation and regulation in Alzheimer\u2019s disease","volume":"70","author":"Y Shen","year":"2003","journal-title":"Prog Neurobiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.exger.2006.05.016","article-title":"Early detection of Alzheimer\u2019s disease using neuroimaging","volume":"42","author":"L Mosconi","year":"2007","journal-title":"Exp Gerontol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"I Morales","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1089\/ars.2011.4277","article-title":"Synaptic mitochondrial pathology in Alzheimer\u2019s disease","volume":"16","author":"H Du","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer\u2019s disease","volume":"129","author":"A Hye","year":"2006","journal-title":"Brain"},{"key":"ref6","article-title":"Plasma proteins predict conversion to dementia from prodromal disease","author":"A Hye","year":"2014","journal-title":"Alzheimers Dement"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0197-4580(01)00340-2","article-title":"Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer\u2019s disease brain contribute to neuronal death","volume":"23","author":"DA Butterfield","year":"2002","journal-title":"Neurobiol Aging"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/94.9.485","article-title":"Increased oxidative stress in Alzheimer\u2019s disease as assessed with 4-hydroxynonenal but not malondialdehyde","volume":"94","author":"LT McGrath","year":"2001","journal-title":"QJM"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ageing\/21.2.91","article-title":"Plasma concentrations of vitamins A and E and carotenoids in Alzheimer\u2019s disease","volume":"21","author":"Z Zaman","year":"1992","journal-title":"Age Ageing"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archneur.59.6.972","article-title":"Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease","volume":"59","author":"D Pratico","year":"2002","journal-title":"Arch Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9","article-title":"Increased 8,12-iso-iPF2alpha-VI in Alzheimer\u2019s disease: correlation of a noninvasive index of lipid peroxidation with disease severity","volume":"48","author":"D Pratico","year":"2000","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15287398109529960","article-title":"Evaluation of the cytotoxicity of tricyclic antidepressants in primary cultures of rat hepatocytes","volume":"7","author":"DB Mitchell","year":"1981","journal-title":"J Toxicol Environ Health"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.freeradbiomed.2012.08.596","article-title":"Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics","volume":"53","author":"A Cocciolo","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","article-title":"Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer\u2019s disease","volume":"39","author":"LE Rojo","year":"2008","journal-title":"Arch Med Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","article-title":"Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease","volume":"67","author":"M Thambisetty","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.2011.381","article-title":"Plasma clusterin and the risk of Alzheimer disease","volume":"305","author":"EM Schrijvers","year":"2011","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1074\/jbc.M113.502690","article-title":"Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration","volume":"289","author":"AA Asuni","year":"2014","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e50237","DOI":"10.1371\/journal.pone.0050237","article-title":"No diagnostic value of plasma clusterin in Alzheimer\u2019s disease","volume":"7","author":"E Silajdzic","year":"2012","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jnr.490330302","article-title":"Human serum stimulates Alzheimer markers in cultured hippocampal neurons","volume":"33","author":"GJ Brewer","year":"1992","journal-title":"J Neurosci Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/S0317167100029875","article-title":"Antibodies in serum of patients with Alzheimer\u2019s disease cause immunolysis of cholinergic nerve terminals from the rat cerebral cortex","volume":"16","author":"HF Bradford","year":"1989","journal-title":"Can J Neurol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.36.2.276","article-title":"Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls","volume":"36","author":"M Hirayama","year":"1986","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(90)91013-7","article-title":"Serum cytotoxicity to human and rat oligodendrocytes in culture","volume":"517","author":"TCOA Ruijs","year":"1990","journal-title":"Brain Research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0022-510X(84)90092-3","article-title":"Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera","volume":"65","author":"K Bradbury","year":"1984","journal-title":"J Neurol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00314713","article-title":"Multiple sclerosis: demyelination and myelination inhibition of organotypic tissue cultures of the spinal cord by sera of patients with multiple sclerosis and other neurological diseases","volume":"218","author":"J Ulrich","year":"1978","journal-title":"J Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"42619","DOI":"10.1074\/jbc.M508416200","article-title":"Human serum from patients with septic shock activates transcription factors STAT1, IRF1, and NF-kappaB and induces apoptosis in human cardiac myocytes","volume":"280","author":"A Kumar","year":"2005","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1017\/S1041610210001067","article-title":"The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70\u201390 years","volume":"22","author":"PS Sachdev","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"RC Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0197-0186(95)00023-2","article-title":"Effect of ammonia on endocytosis and cytokine production by immortalized human microglia and astroglia cells","volume":"27","author":"CL Atanassov","year":"1995","journal-title":"Neurochem Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.410290207","article-title":"Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection","volume":"29","author":"S Peudenier","year":"1991","journal-title":"Ann Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-0186(05)80010-5","article-title":"Metabolic and cellular characterization of immortalized human microglial cells under heat stress","volume":"33","author":"FM de Gannes","year":"1998","journal-title":"Neurochem Int"},{"key":"ref32","first-page":"169","article-title":"Complement C8 deficiency with recurrent meningococcemia: examination of meningococcal opsonization","volume":"21","author":"AS Kemp","year":"1985","journal-title":"Aust Paediatr J"},{"key":"ref33","first-page":"936","article-title":"Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing","volume":"47","author":"J Carmichael","year":"1987","journal-title":"Cancer Res"},{"key":"ref34","first-page":"129","article-title":"Comparison of chemosensitivity tests: clonogenic assay versus MTT assay","volume":"56","author":"K Kawada","year":"2002","journal-title":"Acta Med Okayama"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0003-2697(73)90094-8","article-title":"An improved cycling assay for nicotinamide adenine dinucleotide","volume":"53","author":"C Bernofsky","year":"1973","journal-title":"Anal Biochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/01480540701688865","article-title":"In vitro and in vivo evaluation of various carbonyl compounds against cyanide toxicity with particular reference to alpha-ketoglutaric acid","volume":"31","author":"R Bhattacharya","year":"2008","journal-title":"Drug Chem Toxicol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.tiv.2008.05.006","article-title":"Cytotoxicity evaluation of three pairs of hexabromocyclododecane (HBCD) enantiomers on Hep G2 cell","volume":"22","author":"X Zhang","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/jnr.22650","article-title":"Adaptation of microplate-based respirometry for hippocampal slices and analysis of respiratory capacity","volume":"89","author":"RA Schuh","year":"2011","journal-title":"J Neurosci Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12640-013-9420-5","article-title":"Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro","volume":"25","author":"N Braidy","year":"2014","journal-title":"Neurotox Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2047-9158-2-20","article-title":"Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts","volume":"2","author":"N Braidy","year":"2013","journal-title":"Transl Neurodegener"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-61779-382-0_3","article-title":"High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle","volume":"810","author":"D Pesta","year":"2012","journal-title":"Methods Mol Biol"},{"key":"ref42","article-title":"Staining proteins in gels with coomassie blue","author":"RJ Simpson","year":"2007","journal-title":"CSH Protoc 2007"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/pmic.200900437","article-title":"Scaffold: a bioinformatic tool for validating MS\/MS-based proteomic studies","volume":"10","author":"BC Searle","year":"2010","journal-title":"Proteomics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"A Keller","year":"2002","journal-title":"Anal Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","article-title":"Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein","volume":"4","author":"Y Ishihama","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/pmic.200900651","article-title":"Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction","volume":"10","author":"YA Lim","year":"2010","journal-title":"Proteomics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-5956-12-5","article-title":"Plasma protein profiling of Mild Cognitive Impairment and Alzheimer\u2019s disease using iTRAQ quantitative proteomics","volume":"12","author":"F Song","year":"2014","journal-title":"Proteome Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0161-5890(80)90144-3","article-title":"Titers of nine complement components, conglutinin and C3b-inactivator in adult and fetal bovine sera","volume":"17","author":"RP Triglia","year":"1980","journal-title":"Mol Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0022029901005337","article-title":"Complement factor B and the alternative pathway of complement activation in bovine milk","volume":"69","author":"P Rainard","year":"2002","journal-title":"J Dairy Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0006-8993(94)91541-5","article-title":"Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture","volume":"633","author":"G Defazio","year":"1994","journal-title":"Brain Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00001756-199604100-00009","article-title":"CD59 expression and complement susceptibility of human neuronal cell line (NTera2)","volume":"7","author":"C Agoropoulou","year":"1996","journal-title":"Neuroreport"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pscychresns.2008.04.003","article-title":"Blood-brain barrier permeability in Alzheimer\u2019s disease: a case-control MRI study","volume":"171","author":"JM Starr","year":"2009","journal-title":"Psychiatry Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","article-title":"Microvascular injury and blood-brain barrier leakage in Alzheimer\u2019s disease","volume":"28","author":"BD Zipser","year":"2007","journal-title":"Neurobiol Aging"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer\u2019s disease","volume":"183","author":"MI Fonseca","year":"2009","journal-title":"J Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-8993(97)00850-0","article-title":"Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain","volume":"769","author":"Y Shen","year":"1997","journal-title":"Brain Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"J Rogers","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64604-4","article-title":"Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis","volume":"157","author":"SK Singhrao","year":"2000","journal-title":"Am J Pathol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0006-8993(95)00041-N","article-title":"Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease","volume":"675","author":"DG Walker","year":"1995","journal-title":"Brain Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","article-title":"Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer\u2019s disease","volume":"20","author":"LB Yang","year":"2000","journal-title":"J Neurosci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(91)90071-3","article-title":"Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain","volume":"544","author":"PL McGeer","year":"1991","journal-title":"Brain Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-8993(93)91698-R","article-title":"Synthetic Alzheimer amyloid beta\/A4 peptides enhance production of complement C3 component by cultured microglial cells","volume":"601","author":"S Haga","year":"1993","journal-title":"Brain Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(01)01842-0","article-title":"Complement activation by neurofibrillary tangles in Alzheimer\u2019s disease","volume":"305","author":"Y Shen","year":"2001","journal-title":"Neurosci Lett"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s00415-008-0006-8","article-title":"Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer\u2019s disease","volume":"255","author":"M Thambisetty","year":"2008","journal-title":"J Neurol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/13547500802445199","article-title":"The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer\u2019s disease patients responding to treatment with rosiglitazone","volume":"13","author":"EL Akuffo","year":"2008","journal-title":"Biomarkers"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.molimm.2008.04.025","article-title":"C4b-binding protein in Alzheimer\u2019s disease: binding to Abeta1\u201342 and to dead cells","volume":"45","author":"LA Trouw","year":"2008","journal-title":"Mol Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(90)90251-4","article-title":"Antibodies to fibronectin bind to plaques and other structures in Alzheimer\u2019s disease and control brain","volume":"118","author":"J Howard","year":"1990","journal-title":"Neurosci Lett"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(01)02286-8","article-title":"Fibronectin modulation by A beta amyloid peptide (25\u201335) in cultured astrocytes of newborn rat cortex","volume":"314","author":"MT Moreno-Flores","year":"2001","journal-title":"Neurosci Lett"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20070304","article-title":"Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer\u2019s disease","volume":"204","author":"J Paul","year":"2007","journal-title":"J Exp Med"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition","volume":"107","author":"AG Vlassenko","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00004647-199806000-00005","article-title":"Cerebral glucose transport and metabolism in preterm human infants","volume":"18","author":"WJ Powers","year":"1998","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref71","first-page":"1512","article-title":"Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people","volume":"70","author":"M Wirth","year":"2013","journal-title":"JAMA Neurol"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Ossenkoppele R, Madison C, Oh H, Wirth M, van Berckel BN, et al. (2013) Is Verbal Episodic Memory in Elderly with Amyloid Deposits Preserved Through Altered Neuronal Function? Cereb Cortex.","DOI":"10.1016\/j.jalz.2013.05.771"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer\u2019s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons","volume":"105","author":"WS Liang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s007020050174","article-title":"Activities of key glycolytic enzymes in the brains of patients with Alzheimer\u2019s disease","volume":"106","author":"M Bigl","year":"1999","journal-title":"J Neural Transm"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","article-title":"Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses","volume":"101","author":"EM Blalock","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1523\/JNEUROSCI.2350-05.2005","article-title":"Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer\u2019s disease pathogenesis","volume":"25","author":"RA Velliquette","year":"2005","journal-title":"J Neurosci"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"37245","DOI":"10.1074\/jbc.M112.366195","article-title":"Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid beta and other toxins by decreasing mitochondrial respiration and reactive oxygen species production","volume":"287","author":"JT Newington","year":"2012","journal-title":"J Biol Chem"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2004.11.010","article-title":"Oxidative modification of proteins in the frontal cortex of Alzheimer\u2019s disease brain","volume":"27","author":"MA Korolainen","year":"2006","journal-title":"Neurobiol Aging"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2014.03.027","article-title":"Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease","volume":"71","author":"F Di Domenico","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"ref80","first-page":"520152","article-title":"Altered proteolysis in fibroblasts of Alzheimer patients with predictive implications for subjects at risk of disease","volume":"2014","author":"A Mocali","year":"2014","journal-title":"Int J Alzheimers Dis"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3233\/JAD-130728","article-title":"Characterization of mitochondrial dysfunction in the 7PA2 cell model of Alzheimer\u2019s disease","volume":"37","author":"N Krako","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-132165","article-title":"Metabolomic signatures in peripheral blood associated with Alzheimer\u2019s disease amyloid-beta-induced neuroinflammation","volume":"42","author":"E Kim","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbalip.2010.01.009","article-title":"The neurobiology of isoprostanes and Alzheimer\u2019s disease","volume":"1801","author":"D Pratico","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000289224","article-title":"Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer\u2019s disease","volume":"7","author":"EJ Mufson","year":"2010","journal-title":"Neurodegener Dis"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2013\/234572","article-title":"Reevaluating Metabolism in Alzheimer\u2019s Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle Model","volume":"2013","author":"JT Newington","year":"2013","journal-title":"Journal of Neurodegenerative Diseases"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cercor\/4.2.138","article-title":"Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital","volume":"4","author":"C Bouras","year":"1994","journal-title":"Cereb Cortex"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer\u2019s disease","volume":"45","author":"JL Price","year":"1999","journal-title":"Ann Neurol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-12-385883-2.00003-5","article-title":"Protein quality control in neurodegenerative disease","volume":"107","author":"JE Gestwicki","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2013.01.027","article-title":"Differential molecular chaperone response associated with various mouse adapted scrapie strains","volume":"538","author":"AA Asuni","year":"2013","journal-title":"Neurosci Lett"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.febslet.2012.07.023","article-title":"Protein disulfide isomerases in neurodegeneration: from disease mechanisms to biomedical applications","volume":"586","author":"CI Andreu","year":"2012","journal-title":"FEBS Lett"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.febslet.2013.01.067","article-title":"Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75\/mortalin","volume":"587","author":"LA Voloboueva","year":"2013","journal-title":"FEBS Lett"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2990.1993.tb00400.x","article-title":"Heat shock protein (hsx70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state","volume":"19","author":"PJ Harrison","year":"1993","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1212\/WNL.41.3.345","article-title":"Expression of heat shock proteins in Alzheimer\u2019s disease","volume":"41","author":"JE Hamos","year":"1991","journal-title":"Neurology"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0968-0004(96)10071-2","article-title":"ERM proteins: head-to-tail regulation of actin-plasma membrane interaction","volume":"22","author":"S Tsukita","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1083\/jcb.201304052","article-title":"The actin-binding ERM protein Moesin binds to and stabilizes microtubules at the cell cortex","volume":"202","author":"S Solinet","year":"2013","journal-title":"J Cell Biol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1189\/jlb.0212078","article-title":"Fueling the flame: bioenergy couples metabolism and inflammation","volume":"92","author":"TF Liu","year":"2012","journal-title":"J Leukoc Biol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature12752","article-title":"The nexus of chromatin regulation and intermediary metabolism","volume":"502","author":"P Gut","year":"2013","journal-title":"Nature"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement biosynthesis in the central nervous system","volume":"6","author":"SR Barnum","year":"1995","journal-title":"Crit Rev Oral Biol Med"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fncel.2014.00075","article-title":"Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders","volume":"8","author":"E Maffioletti","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"ref100","article-title":"Variance in the identification of microRNAs deregulated in Alzheimer\u2019s disease and possible role of lincRNAs in the pathology: The need of larger datasets","author":"P Lau","year":"2014","journal-title":"Ageing Res Rev"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","article-title":"Up-regulated production and activation of the complement system in Alzheimer\u2019s disease brain","volume":"154","author":"K Yasojima","year":"1999","journal-title":"Am J Pathol"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2990.2005.00652.x","article-title":"Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype","volume":"31","author":"M Tanskanen","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","article-title":"Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: a systematic review and replication study","volume":"38","author":"SJ Kiddle","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"e28527","DOI":"10.1371\/journal.pone.0028527","article-title":"Plasma biomarkers of brain atrophy in Alzheimer\u2019s disease","volume":"6","author":"M Thambisetty","year":"2011","journal-title":"PLoS One"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/WAD.0b013e318239dcbd","article-title":"Plasma levels of complement 4a protein are increased in Alzheimer\u2019s disease","volume":"26","author":"S Bennett","year":"2012","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-2010-100279","article-title":"Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer\u2019s disease","volume":"21","author":"A Guntert","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/pmic.200300495","article-title":"Mining biomarkers in human sera using proteomic tools","volume":"4","author":"R Zhang","year":"2004","journal-title":"Proteomics"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2377-7-14","article-title":"Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer\u2019s disease","volume":"7","author":"JW Lee","year":"2007","journal-title":"BMC Neurol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/01.STR.0000189721.31432.26","article-title":"Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia","volume":"36","author":"M van Oijen","year":"2005","journal-title":"Stroke"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2008.03.010","article-title":"Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer\u2019s disease","volume":"436","author":"SM Jung","year":"2008","journal-title":"Neurosci Lett"},{"key":"ref111","first-page":"47","article-title":"Cerebrospinal fluid protein variations in common to Alzheimer\u2019s disease and schizophrenia","volume":"3","author":"G Johnson","year":"1992","journal-title":"Appl Theor Electrophor"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1179\/016164106X98035","article-title":"Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer\u2019s disease and non-demented elderly subjects","volume":"28","author":"EM Castano","year":"2006","journal-title":"Neurol Res"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/pmic.200300475","article-title":"Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma","volume":"3","author":"HL Yu","year":"2003","journal-title":"Proteomics"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.jnen.0000196133.74087.cb","article-title":"Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain","volume":"65","author":"T Arai","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-2006-9105","article-title":"Thrombin and inflammatory proteins are elevated in Alzheimer\u2019s disease microvessels: implications for disease pathogenesis","volume":"9","author":"P Grammas","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0304-3940(92)90065-F","article-title":"Thrombin accumulation in brains of patients with Alzheimer\u2019s disease","volume":"146","author":"H Akiyama","year":"1992","journal-title":"Neurosci Lett"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","article-title":"Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer\u2019s disease","volume":"118","author":"M Puchades","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00001756-200204160-00015","article-title":"Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients","volume":"13","author":"P Davidsson","year":"2002","journal-title":"Neuroreport"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0116092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T03:50:13Z","timestamp":1566445813000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0116092"}},"subtitle":[],"editor":[{"given":"Wenhui","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,18]]},"references-count":118,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0116092","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,18]]}}}